Evidence map›Paper›PMID 29204780›Full record

ArticleInflammopharmacology2018

Silver oxide nanoparticles alleviate indomethacin-induced gastric injury: a novel antiulcer agent.

Neveen A Salem, Mohammed A Wahba, Wael H Eisa, Marwa El-Shamarka, Wagdy Khalil

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Flavonoid-RichInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. AgPharmaceuticals (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Neveen A SalemBiochemistry Department, Faculty of Science, Al Faisalia, King Abdulaziz University, Jeddah, Saudi Arabia. dr_nsalem@yahoo.com.ORCID http://orcid.org/0000-0003-1520-122X
Mohammed A WahbaInorganic Chemistry Department, National Research Centre, Dokki, Cairo, Egypt.
Wael H EisaPhysics Division, Spectroscopy Department, National Research Center (NRC), Dokki, Egypt.
Marwa El-ShamarkaMedical Research Division, Narcotics, Ergogenic Aids and Poisons Department, National Research Centre, Dokki, Egypt.
Wagdy KhalilCell Biology Department, National Research Centre, Dokki, Cairo, Egypt.
National Research Centre · EGKing Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver and silver oxides are gaining interest in medical applications for their prominent antibacterial and antimicrobial potentials. Recent studies suggest that nanosilver oxide has remarkable anti-inflammatory effects and enhances wound healing. Nevertheless, its effect on gastric ulcer has not yet been illustrated. Thus the current study aimed to explore the prospect protective effect of nanosilver oxide against indomethacin-induced gastric ulcer. A new approach has been followed to synthesize nanosilver oxide. X-ray diffraction, UV-Vis spectroscopy and transition electron microscope techniques have been successfully used to characterize the synthesized nanoparticles. Treatment of ulcerated rats with different doses of nanosilver oxide especially (175 and 350 ppm/p.o.) alleviated adverse effects of indomethacin-induced gastric injury as demonstrated by decreasing ulcer index and elevating % of ulcer inhibition. These positive effects excelled those exerted by the reference antiulcer drug omeprazole. Nanosilver oxide suppressed gastric inflammation by reducing myeloperoxidase, tumor necrosis alpha, interleukin 1beta and interferon gamma. Moreover, nanosilver oxide halted gastric oxidative stress via inhibiting lipid  peroxidation and enhancing glutathione and paraoxonase-1. Regarding gastric apoptosis, nanosilver oxide down regulated the expression of caspase 9, tumor protein 53, and nuclear factor kappa B and allograft inflammatory factor-1 genes. These findings emphasize the antiulcerogenic potential of nanosilver oxide against indomethacin-induced gastric ulcers which are multi-factorial including anti-inflammatory, antioxidant and antiapoptotic effects.

Indexed as

Metal NanoparticlesAnimalsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsAnti-Ulcer AgentsApoptosisDose-Response Relationship, DrugIndomethacinLipid PeroxidationMaleMicroscopy, Electron, TransmissionOxidative StressOxidesRatsRats, WistarAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsAnti-Ulcer Agentsdisilver oxideIndomethacinOxidesSilver CompoundsApoptosisGastric ulcerIndomethacinInflammationOxidative stressSilver oxide nanoparticles

Identifiers

PMID29204780
OpenAlexW2774495943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.